. risk of operative mortality and postoperative complications in surgical patients. No data examining obesity as • factor In cadaveric renal transplantation were available. We therefore matched obese patients undergoing . cadaveric renal transplantation with nonobese control patients and retrospectively analyzed mortality. mor~ bldlty. and graft survival In each group. Patients were JDatched for age. sex, diabetes mellitu8, PRA, graft number, cardiovascular disease, date of transplantation. and posttransplant immunosuppression. There were significant differences found in mortality (11'" in obese va. 2% in nonobese patients, PsO.O 1). immediate graft function (38'" in obese V8. 64% in nonobese patients. psO.Ol), I-year graft survival (66'" in obese vs. 84 PsO.02) were all significantly more common in the obese group. These results suggest that an attempt at significant weight reduction is indicated in obese patients prior to renal transplantation.
Obesity is generally thought to be associated with an increased risk in surgical patients (1) . Operative mortality tends to be higher (2-4), and postoperative complications, especially wound infections (1.3-5) , are more common. There are however little data describing the results after cadaveric renal transplantation in obese patients. The experience at the University of Pittsburgh was retrospectively analyzed to determine patient and graft survival as well as the incidence of various posttransplant complications. Obesity was defined as a body mass index of greater than 30, a commonly accepted definition (6, 1). A matched control group of nonobese renal transplant recipients was used for comparison.
MATERIALS AND METHODS
The medical records of obese patients with end-stage renal disease undergoing cadaveric renal transplantation between January 1986 and December 1988 at the University of Pittsburgh were reviewed. Livingrelated kidney and multiple-organ transplant recipients were excluded from the study. Obesity was defined as a body mass index (BMI = weight in Kg/height in mt) of ~30 (7). It should be noted that morbid obesity is defined as a BMI >35. Thus, only 13 of our 46 obese patients could be described as morbidly obese. The parameters examined included: (1) patient survival; (2) graft survival; (3) initial graft function (defined as clearance of creatinine without dialyaia by 1 week poettranaplant); (4) duration of the operation; (5) need for reintubation postoperatively, after initial extubation; (6) admiasion to an intensive care unit; (7) colonic diatension requiring either coIonOlCOpic or surgical decompression; (8) wound complications includinr hematoma, infection, and dehiacence; (9) urinary-tract infections requiring antloiotic therapy; (10) duration of initial hospita1ization; and (11) new-onset diabetes..
n.e records of control (oonobese, BMI s27 for men, :s25 for women) patients were examined (or the same parameters as the obese patients.
Each obese patient was matched with a control patient for age, sex, transplant graft number, diabetes mellitus at the time of transplantation, pretranaplant panel-reactive antl'body within 30%, and pretranaplant cardiovascular disease. defined by either a thallium streas test or coronary angiography and/or myocardial function by nuclear imaging (MUGA) or echocardiography. Control patients were also matched for date of transplantation (within 15 months) and posttranaplant irDJnuDOSuppression. From January 1986 through January 1987, CaA and prednisone immunosuppression was used in all patients. From January 1987 through January 1988, approximately SO% of the transplant patients followed a triple-drug (azathioprine, CIA, and prednisone) immunosuppression protocol; the remaining patients were maintained on a CsA and prednisone regimen. After February 1988, all patients received the triple-drug protocol. Steroid-resistant rejection episodes were treated with a 10-14 day course of monoclonal antibody (OKT3). Patients with a high PRA (>SO%) and/or previous transplants were tleated with induction OKT3 therapy.
StotistictJl methods. The statistical significance of differences between proportions was determined by chi-square analysis with Yates' correction. Data were also analyzed between the matched subjects (or differences in proportions by the McNemar's test (8). Comparison among groups was performed by t test for independent samples. Survival analysis was done by Mantel-Cox test. Probability less than 0.05 was considered significant. Data are given as mean values. Table 1 demonstrates the postoperative morbidity and mortality observed in the 2 patient groups. Using the McNemar's test, significantly more patient deaths occurred during the initial hospital period in the obese group (5) than in the control group (1) . Sepsis was the cause of all deaths in the obese patients: two of pulmonary etiology, two following cecal perforation, and one due to an abdominal abscess after a long and complicated hospital course_ The patient death in the control group was secondary to sepsis caused by pyelonephritis. Figure  1 depicts patient survival over a 2-year follow-up period and shows no statistical difference between the groups but illustrates a trend toward poorer survival in the obese patients; 1-year patient survival 89% in obese patients vs. 98% in control patients (Fig. 1) . The overall patient survival at the University of Pittsburgh during this period was 93% at 1 year and 90% at 2 years after cadaveric renal transplantation. Initial allograft function and ultimate graft survival were both significantly worse in the obese group. Thirty-eight per· cent of the obese patients were clearing creatinine by 1 week posttransplant versus 64% of the control group (PsO.01, Table  1 ). One-year acturial graft survival was 66% in the obese versus 84% in the nonobese group, PsO.05 (Fig. 1) .
RESULTS
Differences between the patient groups were noted in duration of surgery and hospitalization, both significantly longer in the obese patients ( Table 1 ). The groups were matched, therefore no differences were appreciated in mean age, sex, presence of diabetes mellitus, PRA, transplantation date, or immunosuppressive protocol (Table 2) .
Significantly increased morbidity occurred in the obese group including 10 intensive-care-unit admissions, 8 reintubations, and 10 wound complications (either hematoma, infection, or dehiscence, Table 1 ). There was no difference between the obese and control groups in the occurrence of urinary-tract infections or colonic distension requiring colonoscopic or surgical intervention. Two patients in the obese group however died because of colonic distension and subsequent sepsis. Significantly more obese patients who were not diabetic before transplantation required insulin therapy for glucose control after transplantation.
DISCUSSION
Obesity is known to increase the risk of surgical procedures (1), but little data are available regarding the risks of obesity Table  2 ), as suggested by Pasulka (1), were seen in our obese patients. Additionally, complications of increased stroke work were plausible in 2 control patients and .. obese patients. Postoperative pulmonary edema occurred as a result of fluid administration in. the setting of end-stage renal disease, most often in patients WIth some degree of myocardial dysfunction. Ultrafiltration therapy resolved the problem in all cases. Admission to an intensive care unit was more common in the obese group (20% vs. 2%) and was prompted by the need for reintubation (8 patients,4 with associated sepsis) in most instances. Two obese patients required leu admission for cardiovascular reasons. In 1 case this was due to a perioperative myocardial infarction and in another, a supraventricular arrthymia.
The most frequently reported postoperative complication in obese patients is wound infection (2-4) and wound disruption (2, 5). Postlethwait bas suggested that longer operations (due to technical difficulties), increased trauma to the abdominal wall from vigorous retraction, the low resistance of fat to infection, and an inability to obliterate dead space in the abdominal wall fat are all contributing factors (3). The increased wound area in obese patients has also been postulated as a major factor leading to higher rates of wound infection in these patients (12). We observed a significantly higher inci· dence of wound complications in our obese patients (20% vs. 2% in the nonobese patients, PsO.01) and also noted longer operations in the obese group. Transplant nephrectomy, urine leak, and hematoma are associated with a higher incidence of wound infection in the transplant population (13, 14) . The single wound complication in the control group was associated with a urine leak. Four of the 10 wound complications seen in the obese group occurred after transplant nephrectomy, and one followed 8 wound hematoma. The remaining five, however, may reflect the combined negative effects of prolonged surgery and the low resistance of fat to infection (3) . The latter factor may be amplified in the immunosuppressed state that accompanies renal transplantation. 
